アナプラスティックリンパ腫キナーゼによるリガンド受容の構造的基礎
Tongqing Li1,2, Steven E Stayrook1,2, Yuko Tsutsui1,2
1Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Nature
|November 25, 2021
まとめ
アナプラスティックリンパ腫キナーゼ (ALK) の構造は,そのグリシンに富んだドメインが受容体の活動をどのように調節するかを明らかにする. この発見は,小児神経芽細胞腫を含む,ALKが誘発する癌に対する新しい治療戦略を提供します.
科学分野:
- 分子生物学
- 構造生物学
- 癌の研究
背景:
- アナプラスティックリンパ腫キナーゼ (ALK) は,神経系の発達に不可欠な受容体チロシンキナーゼである.
- 発育後,ALKは学習,記憶,エネルギー消費に影響を与え,肥満を予防します.
- 異常なALK信号は様々な癌を誘発する 特に小児神経芽細胞腫
研究 の 目的:
- 細胞外グリシン豊富な領域 (GRD) によってALK調節の構造的基礎を解明する.
- ALKがレギュレータリガンドに反応し,二重複合体を形成する方法を理解する.
- ALKに関連する悪性腫瘍の潜在的治療標的を特定する.
主な方法:
- ALK GRDの構造を決定するX線結晶学.
- ALK GRDとそのリガンドの融合タンパク質を設計し,二重複合体を捕捉する.
- ポリグリシン延長ループ (PXL) のサイト指向型変異と抗体相互作用の研究.
主要な成果:
- ALK GRDの結晶構造が明らかにされ,受容体の活性を調節する役割が詳細に示された.
- GRDの重複性グリシンが,リガンド結合部位とPXLを分離する硬いヘリクスを形成することを示した.
- PXLをALK二分化とインター受容体シグナル伝達の主な媒介体として特定した.
結論:
- ALKの非典型的構造,特にPXLは,そのリガンド媒介の調節に中心的です.
- 変異や抗体によるPXL機能の破壊は,ALKの活性化を廃止することができます.
- これらの発見は,小児神経芽細胞腫のような,ALKによって引き起こされる癌に対する新しい治療法を示しています.
関連する概念動画
01:26Receptor Tyrosine Kinases
15.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.1K
01:22Amplifying Signals via Enzymatic Cascade
13.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
02:40Ligand Binding Sites
14.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.1K
01:00Enzyme-linked Receptors
80.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.6K
01:22PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K